PPA Joins Patients in Harrisburg to Advocate for Access to Meds

Marion Mass, M.D. asks lawmakers to “roll up their sleeves” and work with physicians on behalf of patients

Non medical switching happens when a patient is changed to a different medication because the PBM-imposed formularies, the drugs that are covered by insurers have changed. On Feb 18, 2020, PPA’s Marion Mass, MD stood beside patient advocates and gave testimony to The Consumer Affairs Committee of the Pa State House regarding Non Medical switching. Highlights below.

Mass’s testimony excerpts:

“I thank you for this opportunity to testify on behalf of Pennsylvania patients. Other than practicing as a pediatrician in Bucks and Montgomery County of Pennsylvania, I have no conflict of interest.  I paid my own way to come here today, as I do for every advocacy trip.

House Bill 853 is vital to protecting the health and well-being of patients, especially those with serious chronic medical problems. Patients, especially those with chronic illness and preexisting conditions,  deserve consistent benefits during the tenure of their insurance plans.

Let me start with a story.  Ryan was diagnosed with complex partial seizures at age 17, and for most of the last 20 years he has been well controlled on Topomax and Lamictal.  Initially, he had excellent coverage for brand names of both, but his out of pocket cost for the brand name shot up suddenly and unexpectedly to $320 for a 3 month supply, compared to $10 for the generic.   Ryan switched to generics three separate times during the middle of the policy year.  With two of the three switches, he suffered breakthrough seizures.  For those listening who are unaware, having a seizure not only is a life-threatening event while driving a car, or operating any mechanical or sharp implements, a breakthrough seizure prevents epilepsy sufferers from driving for 6 months.  He also suffered accentuated side effects of memory decline and dizziness, and intense worry of having a seizure at a dangerous time. These were affecting his personal and professional life.  Ryan is a staunch self advocate.  During the time of trying to advocate to get back on brand name, he suffered the disruptive and frustrating process of having to make multiple calls per week, lasting upwards of 30 minutes to his insurance company.  

There are 133,000 epileptic  patients in Pennsylvania.  There are 7.7 million patients with at least 1 chronic disease, and almost half of those have more than 1 chronic disease most necessitating medication. 

  Not all of those patients can advocate as well as Ryan.  Non-medical switching is dangerous to their health, and destructive to their well-being as well as their pocketbooks.

I have seen dozens of affected children personally and am here to tell this committee, and all of Pennsylvania that we must protect treatment decisions made between physicians and the patients for whom they care so that patients get the appropriate access that they deserve at a reasonable cost.

During the questioning, I am happy to reveal more specifically what I know regarding drug pricing, formulary switching and pharmacy benefit managers.  I can share citations from other states that have advanced legislation and have studies regarding the dangerous practice of non- medical switching.

For Pennsylvanians who are living with chronic health conditions, coverage changes allowed by non-medical switching can devastate health and finances. Coverage, when purchased, must remain fair and consistent –patients cannot change plans during the policy year, insurers should not be able to change formulary coverage during the policy year for treatments and services the patient is receiving. It’s time for this committee and all policy makers to think of patients first.  Just like you, did, physicians took an oath… ours was to protect patients.  Let’s roll up our sleeves and do that…. Together. ”

Angie Santiago, lead financial counselor, oncology, Thomas Jefferson University Hospitals, said her job includes helping patients understand what is covered by their health insurance as well as options for additional financial support. She noted that her hospital’s cancer center started having problems with non-medical switching about 18 months ago. She explained that non-medical switching allows insurers to re-categorize prescriptions as pharmacy benefits, requiring the prescription to be filled through a specialty pharmacy outside of the hospital. The switches are also able to occur in the middle of the plan year, preventing patients from switching their health plans, she said. She shared the story of one patient who had to change how he received and paid for his medicine in a few weeks in order to continue to receive his chemotherapy treatment. 

Robert Mentzer, advocate, shared his firsthand experience of non-medical switching when his daughter, who suffers from epilepsy, had her medication switched to a generic version, causing her to have a severe seizure. He explained that when his daughter’s medication was removed from coverage, his family had to choose to either switch to the generic version or pay the $3,250 out-of-pocket cost for the brand prescription. 

Sam Marshall, president and CEO, Insurance Federation of Pennsylvania, noted that health plans provide notice of any change in the drug formulary to allow a doctor to explain why the patient needs to remain on that particular medication. 

Arielle Chortanoff, government affairs director, Independence Blue Cross (IBX), said negative formulary changes are limited and require a 45-day notice to members with appeal rights available. . She noted that the bill fails to address the issue of cost

Dr. Mass said the amount of paperwork that patients and physicians receive from insurance companies and the process of completing these appeals take away from patient care. Chortanoff responded that insurers are developing tools to make it easier for physicians and patients to understand benefits and alleviate the paperwork burden. 

Rep. Oberlander asked Dr. Mass if she had any experience with issues related to diabetes. Dr. Mass said insulin is typically covered to treat diabetes. She added that there’s no transparency on the money flowing between pharmacy benefit managers and pharmaceutical companies despite Pa’s Auditor General Eugene DiPasquale asking for this transparency. Mass later pointed out that Pharmacy Benefit Managers(PBM) are now owned or own insurance companies, and that PBM in a shocking conflict of Interest have the right to receive money from drugmakers. “In any other industry, this would be a kickback” Mass stated. It would be illegal, but kickbacks are legal for PBM and their hospital counterparts the GPO.  

Rep. Neilson asked for more information on the panels making these decisions. Yantis said formulary changes are decided by a group of physicians and clinicians who meet quarterly to review drugs coming into the market and compare them to the drugs currently on the formulary to make recommendations to the Highmark pharmacy team on the best tier for that drug. Dr. Mass said large pharmacies like CVS own pharmacy benefit managers and could create their own panel (with in-house pharmacists) to make decisions. She again noted that pharmacy benefit managers are allowed to accept monetary remuneration from pharmaceutical manufacturers. Rep. Neilson asked if anything has been done legislatively to prescribe how those panels are put together. Yantis said they are put together based on best practices and not a state or federal regulation. 

Doug Furness, senior director of legislative and regulatory affairs, Capital Blue, and Michael Yantis, vice president of state government affairs, Highmark, also testified.

PPA Takes the Hill, Bi-Partisan Style!

Practicing Physicians of Americas cofounder Dr. Marion Mass teamed up with multiple grassroots physicians from around the country to discuss how to protect patients from surprise billing while retaining access to quality medical care. These physicians all paid their own way to come to DC .
Action items, and opportunities for you are coming soon!!! Let’s do this, let’s represent our patients and our profession!

Rep Roger Marshall, M.D., (KS) PPA co-founder Marion Mass, M.D. Rep Neal Dunn, M.D.(Fla) and David Balat MBA of Free2Care 

Reese Tassey, M.D. of Maryland , MPH, Amy Chu, M.D. of Minnesota , MBA and PPA’s Marion Mass, M.D., of Pennsylvania with Rep Dean Phillips of Minnesota 

Representative Cathy McMorris Rodgers of Washington State  with PPA’s Marion Mass, M.D.

Amy Mecozzi Chi, M.D. PPA’s Marion Mass, M.D. and Reese Tassey, M.D. meeting with Senator Tina Smith (Minnesota) staff

PPA’s Marion Mass, M.D. with Purvi Parikh, M.D., of New York and Amy Mecozzi Chu M.D. meeting with Senator Toomey ( Pa)  staff

Jason Adler, M.D., of Maryland Mike Murphy, M.D., of Maryland Carol Pak-Teng, M.D. of New Jersey and Reese Tassey, M.D. catch a break between the house and the senate. These stealth lobbyists needed some fresh air.

Sign to Support Price Transparency in Health Care

Marion Mass, M.D.

Cost transparency is the necessary first step in reducing the unsustainable growing cost of medical care. America is spending half of her tax dollars on health care . Hard working Americans wage growth is being gobbled up by out of pocket costs. Regardless of your personal views on President Trump, his Administration’s Executive Order on transparency will help drive down the cost of health care for ALL Americans. Transparency needs our support as those who run the show want to keep costs hidden. Some in the hospital industry whose cost increases outpace EVERY other sector, are fighting against transparency, teamed up with the health care insurance companies.

We invite YOU to join us in signing the letter below thanking President Trump and the Administration for their bold moves toward achieving real price transparency to create a trusted, functional market in healthcare. Sign at this link: https://actnow.io/DTEUKAo

Thank you to our friends at Patient Rights Advocate, Association of Independent Doctors and AMAC Action, all part of the Free2Care network alongside PPA, for this letter writing campaign.

The Practicing Physicians of America
February 2, 2020

Dear President Trump,

We are writing to thank you for the bold moves you and your Administration are making to bring transparency to healthcare. 

Please stay strong against the forces who want to keep the American people in the dark — blindfolded to know prices before we get care, held hostage without access to our complete health information, and having to pay for our healthcare with a blank check.

Healthcare is Americans’ number one concern. According to the 2019 Harvard Harris Poll, price transparency is a solution that 88 percent of Americans on both sides of the aisle agree on. Meanwhile, studies also show, fear of financial ruin is causing people to avoid seeking the healthcare they need, too often until it’s too late. 
Americans want and deserve full transparency. We want to know the real prices of healthcare before we receive it. We want to know the quality of the care available to us. We want easy, real-time, digital access to our complete health information including prices, clinical history, and payments. Currently, our opaque system makes all that impossible.
We, a cohort of Americans fighting for a better healthcare system, are so grateful that you and your Administration are courageously working to implement the bipartisan transparency laws that already exist. You are doing so despite strong resistance from the Healthcare Industrial Complex — hospitals, insurers, pharmaceutical companies, and the many middle players — who are all capitalizing on patients’ misfortunes.  

Your transparency and interoperability rules will restore Americans’ trust in our healthcare system. These rules will hold the healthcare industry accountable, cut out middle players, and greatly reduce healthcare costs and drug prices by ushering in competition, choice, and the ability for consumers to shop for the best care at the lowest possible price. 
Once we have systemwide healthcare price transparency, we will benefit from a functional healthcare market that operates on free-market principles. We will be able to buy healthcare the way we buy groceries or gasoline, clothing or cars. As healthcare prices plummet, wages and savings accounts will increase. By shining a light on hidden prices and quality information, you will put patients in control of their healthcare, and Americans will become healthier and wealthier. 
On behalf of patients, workers, seniors, employers and taxpayers, thank you again for taking these brave steps toward Making America’s Healthcare Great Again!

Speak on Trump’s Order on Price Transparency in Health Care by 1/29

PPA is encouraging that physicians and others comment to Health and Human Services regarding the Trump Administrations’ most recent Price transparency rule found here.

 This proposed rule complements a previous rule requiring hospitals to post their actual prices online and requiring insurers to disclose (in easy-to-understand format) the prices they now negotiate in secret with hospitals and other providers. The effect would be to enable patients to have some idea before they receive care of what they could end up owing to a provider after the care is delivered and the insurer has issued an Explanation of Benefits (EOB) showing what portion of the cost has been covered. This is a step toward pricing sanity in a more-competitive healthcare marketplace because it supports informed shopping by consumers of medical services. The intent is to enlist and boost the power of consumers in driving down prices.

It is crucial for physicians and patients to comment, as the insurance and hospital industry have come out in full force supporting the now hidden prices that have allowed these two industries to profit themselves while gouging Americans.   This is especially true of the most consolidated hospital systems and dominant insurance companies who use opacity combined with their respective market shares to continually drive prices up.  They simply have no incentive to lower prices. 

PPA’s full comments are below.  You are welcome to copy and paste them in part or whole.  When commenting, adding your personal story regarding how patients are hurt by opaque prices.  

For ease, you can consider copying and pasting a personalized form of these italicized comments: firmly support the current efforts to bring the prices of medical services and procedures into the open and to make those prices easily accessible to our patients—in short, to replace price opacity with price transparency.

Noting that in the proposed rule, HHS also requested comments regarding how to enact transparency of quality, I request transparency in the level of the training attained by those who deliver care, and full disclosure of conflicts of interests of any person or organization the government relies on to define or implement quality in health care.

SUBJECT: CMS-9915-P, Comment on the Proposed Rule Mandating Price Transparency

Ending price OPACITY in favor of price TRANSPARENCY is critical to driving down the costs of all forms of medical care in America.

Practicing Physicians of America (PPA)—a non-profit organization representing thousands of physicians, and a part of the Free-to-Care Coalition, now comprised of 37,000 physicians and 3 million citizens—declare their firm support for the proposed rule requiring insurers to reveal the prices they negotiate with all providers of medical care.

Why Transparency is So Sorely Needed

Each day, the thousands of physicians represented by PPA see the pain in the pocketbook of our patients. We see their foremost concern when they seek medical care. What will this cost?

We have observed our patients incurring higher out-of-pocket costs for health insurance (which ought NEVER to be confused with actual healthcare) that outpace their wage increases and threaten the financial viability of their households. 

More than ever before, the patients we treat in our offices are looking for an accessible, easy-to-understand way to shop for the medical services they need and to control their medical expenses. They would like also to see the exposure and defeat of the hidden forces that drive the relentless rise in premiums in response to excessive costs routinely obscured under the third-party payer system that has dominated American healthcare for close to 50 years and been an engine of our stratospheric rates of inflation in the cost of healthcare.

Price opacity, which has enabled forms of price gouging, has produced the environment we see today in which one in five Americans have had medical bills turned over to collection agencies.

This country desperately needs informed consumers of medical services who have choices at their disposal. Price opacity abets ignorance. Price transparency would vindicate the axiom of Francis Bacon: Nam et ipsa scientia potestas est. (Knowledge is power.) The informed consumer who is capable of making choices in a free marketplace that has been disciplined by competition is the only reliable force for driving down deductibles, premiums, and other costs. 

Do the lobbyists of the health insurance and corporate hospital industries resist calls for the end of opacity and the introduction of transparency? Of course they do. They’ll move heaven and earth to keep the good thing going that has fattened their coffers at the expense of the American patient. Those administrator-heavy industries drive inflation in healthcare by every means our current system has legitimized.

Consider the following.

For certain services and procedures provided on an inpatient basis, hospital charges grew by 42% over the eight-year period from 2007 to 2014.

Similarly, for hospital-based, outpatient care involving the same services and procedures, charges increased by 25%.

The charges for the same services and procedures provided by independent physicians grew by only 6% over the same eight-year period.

Those figures are drawn from a study of insurance claims data by the Health Care Cost Institute that has been the subject of reports in the last year.

Meanwhile, as the resources of the American consumer of medical care are relentlessly squeezed, the profitability of the health insurance industry is a picture of robust financial health

The health insurance and corporate hospital industries benefit from the price opacity that has become the sine qua non of the wildly inflationary, third-party payer system that has dominated the landscape of American healthcare for a half-century.

This scandalous gravy train operating under cover of law and public policy must be halted. Transparency is the brake to do the job. 

Those who enact national policy via regulation need to think FIRST of the needs of American patients and to tell the lobbyists of the health insurance and corporate hospital industries that they will no longer be permitted to be the dominating, decisive voices in the room.

On Quality

In inviting comment, the Departments have raised also the question of how Americans can shop on an informed basis for medical care of high quality that is affordable.

Yes, quality can be hard to define and quantify… although most people recognize it when they see it and can distinguish differences in quality when they experience them.

PPA offers this counsel. If the Departments are contemplating a forum of stakeholders to explore the question of quality in healthcare, it would be essential that any such forum be composed of the full range of stakeholders, most heavily represented by patients and the physicians who deal with them directly and personally.

When it comes to physicians, a “quality forum” should include not only physicians employed by corporations but also independent physicians.

When it comes to hospitals, a “quality forum” should include not only the urban, the regional, the large, and the corporate, but also the smaller, the rural, and the independent.

In addition, the representatives of stakeholders participating in any such forum on quality must be required to declare the interests they represent. The interest of the wider public, American patients—who seek to maintain their choices while simultaneously looking for relief from the high costs related to the medical care they receive and the insurance they carry as a hedge against catastrophic costs—  must be protected from the special and narrow interests that have greatly profited under the current inflationary, increasingly consolidated, increasingly corporatized system that has sprung up and flourished under a system of opacity.

“Quality” as a Function of the Practitioner’s Training 

As shown by surveys over the last decade, one measure for enhancing patients’ recognition of quality would be mandating transparency regarding the level of training acquired by medical practitioners. As the numbers of nurse practitioners and physician’s assistants have grown over a period that has seen some states allow nurse practitioners to “practice” as the functional equivalent of physicians, patients have experienced increasing confusion over who is delivering their care.

There is a vast gulf between the minimum 15,000 hours of clinical experience needed to become a physician and the 500 or 1,000 clinical shadowing hours needed to qualify as a nurse practitioner, or the 2,000 clinical hours required of a physician’s assistant. Given the obvious disparity in-depth and quality of training for these levels of medical practitioner, patients deserve to know the degree of training experienced by their caregivers, and they deserve the freedom to seek care from practitioners of their choosing.

Requiring hospitals and clinics to post prominently the levels of training of all practitioners is a simple step toward transparency. It will minimize confusion and strengthen the ability of the American patient to identify quality. 


Regarding Transparency. PPA firmly supports the current efforts to bring the prices of medical services and procedures into the open and to make those prices easily accessible to our patients—in short, to replace price opacity with price transparency.

Regarding Quality. We counsel that the Departments, in addressing the question of quality, whether by a forum or some other means, seek input from a range of stakeholders, and most particularly from patients and physicians. The Departments must be acutely conscious of the interests and agendas that inform what stakeholders have to say. The Departments should also never lose sight of the inescapable reality that any regulatory mandates on information-gathering that can be predicted to add to the administrative overhead already encumbering the practice of medicine in the United States will be at odds with efforts to create a freer, more-competitive marketplace in which prices can be first be expected to stop rising, and then proceed to fall.

Lastly, PPA calls for transparency in the level of the training attained by those who deliver care.

Speak by Jan. 17 on Pres. Trump’s Executive Order Regarding NP and PA Unsupervised Practice

It’s time for physicians to answer the call for comment on the effect of Section 5 in President Trump’s Executive Order (EO), “Protecting and Strengthening Medicare,” of October 3, 2019.
Section 5 of this order calls for eliminating supervision by physicians of mid-level providers of medical care—nurse practitioners (NPs) and physician assistants (PAs).
More than that, it calls for pay parity (more accurately, “reimbursement parity”) among the same groups by Medicare.
Eventually all third-party payments for care would be leveled (flattened) across physicians, NPs, and PAs, regardless of their clinical training.
Pay parity and elimination of supervision will raise the cost of Medicare, accelerate the corporate takeover of healthcare, deepen the physician shortage, decrease competition in the healthcare sector, and multiply dangerous instances of patients being treated by someone with a fraction of the training received by a physician.
PPA explains this in detail in comments sent to CMS Administrator Seema Verma. To read those comments, see below.
Send comments in an email to PatientsOverPaperwork@cms.hhs.gov and addressed to Administrator Verma by Friday, January 17, 2020,  using the phrase “Scope of Practice” in the subject line.
Comments need not be lengthy. You may copy, paste, and personalize the italicized text shown above. You may consider including a personal story, if you have one, regarding the issues raised by an expansion of the scope of practice for mid-level providers of medical care.
Physicians, it’s time to speak up for your patients and for the value of the training that has defined you!

Administrator Verma:

This e-mail is in response to the call for comment on the effect of Section 5 in the President’s Executive Order (EO), “Protecting and Strengthening Medicare,” of October 3, 2019, with special reference to the issue of Scope of Practice (SOP) and associated pay parity.

To a very great extent, the President’s order has the support of the Practicing Physicians of America (PPA), an organization representing thousands of physicians, and a part of the Free-to-Care Coalition, now comprised of 37,000 physicians and 3 million citizens.

However, PPA objects to Section 5 of the order.

Section 5, although never explicitly mentioning the Nurse Practitioner (NP), will expand the scope of the NP’s role in the American system of delivering medical care.

In what we say next, we do not wish to be misunderstood. The NP is an important member of a medical team, but the team must be led by someone with far greater clinical training and experience. It is simply impossible to equate the 1,000 clinical hours of an NP’s training with the 20,000 clinical hours of a physician’s training.

Physicians are sometimes criticized for raising this point because it is assumed that their motivation is nothing more than the protection of their turf. In fact, our concerns are far more-securely grounded and serious than that, and require evaluation on the merits.

Actual experience and the accumulating data on the gradually expanding scope of the NP’s role in the American healthcare system paint a troublesome picture.

Impact of Overutilization

As a collective workforce, NPs have been criticized for:

Over-authorization of unnecessary procedures;
Over-prescription of medications, including opioids.

At the very least, those tendencies point ultimately to increases in costs, a fiscal impact that is the very opposite of the presumed intent of Section 5.

Impact Favoring the Corporate Takeover of American Healthcare

The increasing corporatization of American healthcare is an undeniable fact that has no demonstrable benefit whatsoever toward restraining inflation and reducing costs in that sector of the economy—a sector that, to the detriment of the general public, is increasingly dominated by special interests, the lobbying dollar, and the campaign contribution.

The largely consolidated hospital industry. These corporate entities, already home to more than 50% of the nation’s physicians, will be incentivized to replace more and more of those physicians with less-expensive practitioners who have significantly less training.

Pharmacy chains. The large chains are already deploying “health hubs” in their brick-and-mortar stores. In some cases, these chains own Pharmacy Benefit Managers (PBM) and insurance companies and have already become anti-competitive, vertically merged behemoths. What is to stop them from exploiting the alignment of interests that are inherent within a vertically merged, integrated entity, and draining even more money from the public’s pocket, not only from increased sales of prescriptions and over-the-counter goods, but also from increased profits through the PBMs they own?

Increasing consolidation and quasi-monopolization that continue to create a less-competitive marketplace are inconsistent with the restraint of inflation and a reduction in costs.

Impact on the Deepening Shortage of Physicians

Another, presumably unintended, consequence of Section 5 will be to deepen the already-critical physician shortage.

Section 5’s call for parity of compensation for services will mean that a corporation that employs physicians will have no economic inventive to retain them because the corporation will receive the same amount for a patient’s time with an NP as it will for the same patient’s time with a physician. The NP, however, will be available to the corporate employer at far less cost than a physician.

The long-term effects will be inescapable.

The rate of attrition among physicians will accelerate.

Fewer young adults will step up to replace them because it will make no sense to incur the high tuition of medical school and undergo the years of training that follow.

We will experience shortages among the ranks of well-trained physicians that go far beyond the tens of thousands already expected.

Impact in Fostering a Less-Competent Workforce for Delivering Medical Care

As taxpayers, we must speak against the absurdity of the government spending equal Medicare dollars for the services of highly trained physicians on one hand and on the other hand the same services (or what may appear superficially to be the same services) from practitioners who have a mere fraction of the physicians’ training and expertise.

Even among older NPs, there is dismay over the declining standard of training now being received by younger NPs via diploma-mill programs that are eager to churn out “graduates” with less training, sometimes conducted largely online.

A Cameo Illustrating the Problem

Not long ago, I met a four-month-old patient and his frantic father, a veteran, whose wife was deployed overseas. Less than 18 hours before, an NP in a large, pediatric hospital had sent the child home, despite obvious symptoms of a bowel obstruction, a surgical emergency. The child was now extremely ill and in great danger. Fortunately, this child was transferred to an ICU setting in time and was able to recover after being treated properly.

Nearly every physician I know can tell at least one such story—and sometimes more than one—from personal experience.

Section 5 will accelerate the replacement of physicians with NPs. In turn, that will multiply occurrences like the one described above. It is unavoidable that the outcomes will, in some cases, be tragic.

Impact Overall

While we understand that the executive order of October 3, 2019, was meant to push back against proposals of “Medicare for All,” Section 5—with its provisions for an expanded scope of practice for non-physicians and pay parity—will have the particular impact of reinforcing the trend in American healthcare toward corporatization, consolidation, and quasi-monopolization.

The large, special interests will complete the process of turning medicine into big-box operations, with low quality and little discipline from a marketplace in which competition thrives.

Decreased competition is never a prescription for restraining and reducing costs.

Decreased competition means that the choices available to all will shrink; and it will be the choices of the underprivileged that will shrink the most. Factor in the consequences of “pay parity” and it will not be long before ALL AMERICANS are paying more. The foreseeable consequence of higher costs in healthcare will certainly be increased public support for a “Medicare for All” system—the very outcome the executive order was meant to avoid.

A Call to Remove Section 5 from the EO

For the reasons cited above, the Practicing Physicians of America call for Section 5 of the EO to be removed. Its implicit expansion of the scope of practice for a less-qualified workforce and its provision for pay parity among professionals of vastly different levels are threats to America’s health and the ability of a competitive marketplace to discipline the pricing of services.

Our Recommendation of a Better Path

The Practicing Physicians of America ask that all federal measures be aimed at strengthening the eroding foundation that, historically, has been responsible for the high quality of American healthcare.

Foster competition.

Increase choices for the public.

Sections B and C of an annotated white paper I was honored to help write in the spring of 2019 offer innovative models for charity care and for expanding access to health care. As a solution to the deepening shortage of physicians, we offer Section D (“Reverse Our Physician Shortage”)

That paper inspired the growth of the Free-to-Care Coalition mentioned above.

The physicians of the Coalition stand ready to speak for our patients and for our profession.


Marion E. Mass, M.D.
Co-founder, on behalf of Practicing Physicians of America